Circulating tumor DNA as a prognostic biomarker in metastatic colorectal cancer: Post-hoc analysis of treatment response and survival outcomes in the ALTER-C-002 study.

Biomol Biomed · 2026 · PMC13170721 · PMID 41732966

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In contrast, patient ID 01003, who presented with a PR at C1, exhibited a decreasing trend in MSAF levels, with an increase observed upon progression to PD at C2 ( Figure 4B ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.